List of Excipients in API amlodipine and olmesartan medoxomil
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing amlodipine and olmesartan medoxomil
Detailed excipient profiles for amlodipine and olmesartan medoxomil
Excipient focus: ANHYDROUS LACTOSE
amlodipine and olmesartan medoxomil drug variants containing ANHYDROUS LACTOSE
amlodipine and olmesartan medoxomil drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
amlodipine and olmesartan medoxomil drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | amlodipine and olmesartan medoxomil | 33342-190 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
amlodipine and olmesartan medoxomil drug variants containing CELLULOSE, MICROCRYSTALLINE
amlodipine and olmesartan medoxomil drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | amlodipine and olmesartan medoxomil | 13668-324 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
amlodipine and olmesartan medoxomil drug variants containing CROSCARMELLOSE SODIUM
amlodipine and olmesartan medoxomil drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | amlodipine and olmesartan medoxomil | 33342-190 |
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-901 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
amlodipine and olmesartan medoxomil drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-901 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing CROSPOVIDONE
Excipient focus: FD&C RED NO. 40
amlodipine and olmesartan medoxomil drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-901 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
amlodipine and olmesartan medoxomil drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-901 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
amlodipine and olmesartan medoxomil drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-901 |
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-947 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
amlodipine and olmesartan medoxomil drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-947 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROGENATED CASTOR OIL
amlodipine and olmesartan medoxomil drug variants containing HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-923 |
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-947 |
| Glenmark Pharmaceuticals Inc USA | amlodipine and olmesartan medoxomil | 68462-566 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing HYDROGENATED CASTOR OIL
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
amlodipine and olmesartan medoxomil drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | amlodipine and olmesartan medoxomil | 68382-927 |
| Zydus Lifesciences Limited | amlodipine and olmesartan medoxomil | 70771-1186 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSES
amlodipine and olmesartan medoxomil drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | amlodipine and olmesartan medoxomil | 68382-927 |
| Zydus Lifesciences Limited | amlodipine and olmesartan medoxomil | 70771-1186 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
amlodipine and olmesartan medoxomil drug variants containing LACTOSE MONOHYDRATE
amlodipine and olmesartan medoxomil drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
amlodipine and olmesartan medoxomil drug variants containing MAGNESIUM STEARATE
amlodipine and olmesartan medoxomil drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
amlodipine and olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | amlodipine and olmesartan medoxomil | 42571-235 |
| Zydus Pharmaceuticals USA Inc | amlodipine and olmesartan medoxomil | 68382-927 |
| Zydus Lifesciences Limited | amlodipine and olmesartan medoxomil | 70771-1186 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
amlodipine and olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 3350
amlodipine and olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
amlodipine and olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | amlodipine and olmesartan medoxomil | 13668-324 |
| Jubilant Cadista Pharmaceuticals Inc | amlodipine and olmesartan medoxomil | 59746-526 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
amlodipine and olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-901 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 8000
amlodipine and olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | amlodipine and olmesartan medoxomil | 50228-365 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
amlodipine and olmesartan medoxomil drug variants containing POLYVINYL ALCOHOL
amlodipine and olmesartan medoxomil drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | amlodipine and olmesartan medoxomil | 59746-526 |
| Zydus Pharmaceuticals USA Inc | amlodipine and olmesartan medoxomil | 68382-927 |
| Zydus Lifesciences Limited | amlodipine and olmesartan medoxomil | 70771-1186 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
amlodipine and olmesartan medoxomil drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-901 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing POVIDONE K30
Excipient focus: POWDERED CELLULOSE
amlodipine and olmesartan medoxomil drug variants containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | amlodipine and olmesartan medoxomil | 59746-526 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing POWDERED CELLULOSE
Excipient focus: SILICON DIOXIDE
amlodipine and olmesartan medoxomil drug variants containing SILICON DIOXIDE
amlodipine and olmesartan medoxomil drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | amlodipine and olmesartan medoxomil | 42571-235 |
| Ascend Laboratories LLC | amlodipine and olmesartan medoxomil | 67877-499 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
amlodipine and olmesartan medoxomil drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-901 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
amlodipine and olmesartan medoxomil drug variants containing STARCH, CORN
amlodipine and olmesartan medoxomil drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and olmesartan medoxomil | 45865-901 |
| Jubilant Cadista Pharmaceuticals Inc | amlodipine and olmesartan medoxomil | 59746-526 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
amlodipine and olmesartan medoxomil drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | amlodipine and olmesartan medoxomil | 67877-499 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing STEARIC ACID
Excipient focus: SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE
amlodipine and olmesartan medoxomil drug variants containing SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | amlodipine and olmesartan medoxomil | 13668-324 |
| >Company | >Ingredient | >NDC |
amlodipine and olmesartan medoxomil drug variants not containing SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE
Excipient focus: TALC
amlodipine and olmesartan medoxomil drug variants containing TALC
amlodipine and olmesartan medoxomil drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
amlodipine and olmesartan medoxomil drug variants containing TITANIUM DIOXIDE
amlodipine and olmesartan medoxomil drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
